{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:04:19Z","timestamp":1791295459962,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s11938-007-0044-9","type":"journal-article","created":{"date-parts":[[2008,3,14]],"date-time":"2008-03-14T14:57:17Z","timestamp":1205506637000},"page":"444-455","source":"Crossref","is-referenced-by-count":33,"title":["Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria"],"prefix":"10.1007","volume":"10","author":[{"given":"Pauline","family":"Harper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Wahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,15]]},"reference":[{"key":"44_CR1","first-page":"2991","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"K.E. Anderson","year":"2001","unstructured":"Anderson KE, Sassa S, Bishop DF, Desnick RJ: Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In The Metabolic and Molecular Bases of Inherited Disease, edn 8. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill; 2001:2991\u20133062.","edition":"8"},{"key":"44_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10545-005-8050-3","volume":"28","author":"M.N. Badminton","year":"2005","unstructured":"Badminton MN, Elder GH: Molecular mechanisms of dominant expression in porphyria. J Inherit Metab Dis 2005, 28:277\u2013286.","journal-title":"J Inherit Metab Dis"},{"key":"44_CR3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(04)15646-8","volume":"363","author":"Z.F. Soonawalla","year":"2004","unstructured":"Soonawalla ZF, Orug T, Badminton MN, et al.: Liver transplantation as a cure for acute intermittent porphyria. Lancet 2004, 363:705\u2013706.","journal-title":"Lancet"},{"key":"44_CR4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/lt.20136","volume":"10","author":"N. Stojeba","year":"2004","unstructured":"Stojeba N, Meyer C, Jeanpierre C, et al.: Recovery from a variegate porphyria by a liver transplantation. Liver Transpl 2004, 10:935\u2013938.","journal-title":"Liver Transpl"},{"key":"44_CR5","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/lt.20620","volume":"11","author":"B.M. McGuire","year":"2005","unstructured":"McGuire BM, Bonkovsky HL, Carithers RL, Jr, et al.: Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl 2005, 11:1590\u20131596.","journal-title":"Liver Transpl"},{"key":"44_CR6","doi-asserted-by":"crossref","first-page":"e1896","DOI":"10.1542\/peds.2006-0833","volume":"118","author":"E.B. Rand","year":"2006","unstructured":"Rand EB, Bunin N, Cochran W, et al.: Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria. Pediatrics 2006, 118:e1896\u2013e1899.","journal-title":"Pediatrics"},{"key":"44_CR7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2006.10.004","volume":"46","author":"S. Wahlin","year":"2007","unstructured":"Wahlin S, Aschan J, Bjornstedt M, et al.: Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis. J Hepatol 2007, 46:174\u2013179.","journal-title":"J Hepatol"},{"key":"44_CR8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jcp.54.7.500","volume":"54","author":"A.C. Deacon","year":"2001","unstructured":"Deacon AC, Elder GH: ACP Best Practice No 165: front line tests for the investigation of suspected porphyria. J Clin Pathol 2001, 54:500\u2013507.","journal-title":"J Clin Pathol"},{"key":"44_CR9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2796.2003.01172.x","volume":"254","author":"C. Andersson","year":"2003","unstructured":"Andersson C, Innala E, B\u00e4kstr\u00f6m T. Acute intermittent porphyria in women: clinical expression, use and experience of exogenous sex hormones. A population-based study in northern Sweden. J Intern Med 2003, 254:176\u2013183.","journal-title":"J Intern Med"},{"key":"44_CR10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.md.0000152454.56435.f3","volume":"84","author":"R.J. Hift","year":"2005","unstructured":"Hift RJ, Meissner PN: An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity. Medicine 2005, 84:48\u201360.","journal-title":"Medicine"},{"issue":"Suppl2","key":"44_CR11","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.33549\/physiolres.930000.55.S2.43","volume":"55","author":"S. Thunell","year":"2006","unstructured":"Thunell S: (Far) outside the box: genomic approach to acute porphyria. Physiol Res 2006, 55(Suppl 2):S43\u2013S66.","journal-title":"Physiol Res"},{"key":"44_CR12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","volume":"142","author":"K.E. Anderson","year":"2005","unstructured":"Anderson KE, Bloomer JR, Bonkovsky HL, et al.: Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 2005, 142:439\u2013450.","journal-title":"Ann Intern Med"},{"key":"44_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(05)17744-7","volume":"365","author":"R. Kauppinen","year":"2005","unstructured":"Kauppinen R: Porphyrias. Lancet 2005, 365:241\u2013252.","journal-title":"Lancet"},{"key":"44_CR14","doi-asserted-by":"crossref","unstructured":"Bonkovsky HL: Neurovisceral porphyrias: what a hematologist needs to know. Hematology Am Soc Hematol Educ Program 2005:24\u201330.","DOI":"10.1182\/asheducation-2005.1.24"},{"key":"44_CR15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2141.2006.06289.x","volume":"135","author":"S. Sassa","year":"2006","unstructured":"Sassa S: Modern diagnosis and management of the porphyrias. Br J Haematol 2006, 135:281\u2013292.","journal-title":"Br J Haematol"},{"key":"44_CR16","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/ndt\/gfg270","volume":"18","author":"A. Schreiber","year":"2003","unstructured":"Schreiber A, Elitok S, Kettritz R: Solving electrolyte disturbances with the Ehrlich reagent. Nephrol Dial Transplant 2003, 18:1217\u20131219.","journal-title":"Nephrol Dial Transplant"},{"key":"44_CR17","unstructured":"The European Porphyria Initiative website. http:\/\/www.porphyria-europe.org . Accessed July 10, 2007."},{"key":"44_CR18","volume-title":"Patient\u2019s and Doctor\u2019s Guide to Medication in Acute Porphyria 2005","author":"S. Thunell","year":"2005","unstructured":"Thunell S, Bjernevik K, Thunell G, Harper P: Patient\u2019s and Doctor\u2019s Guide to Medication in Acute Porphyria 2005. Stockholm: Swedish Porphyria Association; 2005."},{"key":"44_CR19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7326\/0003-4819-144-7-200604040-00023","volume":"144","author":"K.E. Anderson","year":"2006","unstructured":"Anderson KE, Bonkovsky HL, Bloomer JR, Shedlofsky SI: Reconstitution of hematin for intravenous infusion. Ann Intern Med 2006, 144:537\u2013538.","journal-title":"Ann Intern Med"},{"key":"44_CR20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/meta.2001.25587","volume":"50","author":"C. Castelo-Branco","year":"2001","unstructured":"Castelo-Branco C, Vicente JJ, Vanrell JA: Use of gonado-tropin-releasing hormone analog with tibolone to prevent cyclic attacks of acute intermittent porphyria. Metabolism 2001, 50:995\u2013996.","journal-title":"Metabolism"},{"key":"44_CR21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1373\/clinchem.2005.058198","volume":"52","author":"Y. Floderus","year":"2006","unstructured":"Floderus Y, Sardh E, Moller C, et al.: Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion. Clin Chem 2006, 52:701\u2013707.","journal-title":"Clin Chem"},{"key":"44_CR22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1468-1331.2006.01238.x","volume":"13","author":"M.N. Badminton","year":"2006","unstructured":"Badminton MN, Deybach JC: Treatment of an acute attack of porphyria during pregnancy. Eur J Neurol 2006, 13:668\u2013669.","journal-title":"Eur J Neurol"},{"key":"44_CR23","first-page":"201","volume":"48","author":"W.B. Seiden","year":"2003","unstructured":"Seiden WB, Kelly LP, Ali R: Acute intermittent porphyria associated with ovarian stimulation. A case report. J Reprod Med 2003, 48:201\u2013203.","journal-title":"J Reprod Med"},{"key":"44_CR24","doi-asserted-by":"crossref","first-page":"462.e1","DOI":"10.1016\/j.fertnstert.2005.12.065","volume":"86","author":"J.G. Wang","year":"2006","unstructured":"Wang JG, Guarnaccia M, Weiss SF, et al.: Initial presentation of undiagnosed acute intermittent porphyria as a rare complication of ovulation induction. Fertil Steril 2006, 86:462.e1\u2013462.e3.","journal-title":"Fertil Steril"},{"key":"44_CR25","unstructured":"The Drug Database for Acute Porphyria website. http:\/\/www.drugs-porphyria.org . Accessed July 10, 2007."},{"key":"44_CR26","doi-asserted-by":"crossref","unstructured":"Thunell S, Pomp E, Brun A: Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias. Br J Clin Pharmacol 2007 [Epub ahead of print].","DOI":"10.1111\/j.0306-5251.2007.02955.x"},{"key":"44_CR27","unstructured":"Porphyria South Africa website. http:\/\/www.uct.ac.za\/depts\/porphyria . Accessed July 10, 2007."},{"key":"44_CR28","unstructured":"The American Porphyria Foundation website. http:\/\/www.porphyriafoundation.com . Accessed July 10, 2007."},{"key":"44_CR29","unstructured":"The Canadian Porphyria Foundation. http:\/\/www.cpf-inc.ca . Accessed July 10, 2007."},{"issue":"Suppl2","key":"44_CR30","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.33549\/physiolres.930000.55.S2.67","volume":"55","author":"J.C. Deybach","year":"2006","unstructured":"Deybach JC, Badminton M, Puy H, et al.: European porphyria initiative (EPI): a platform to develop a common approach to the management of porphyrias and to promote research in the field. Physiol Res 2006, 55(Suppl 2):S67\u2013S73.","journal-title":"Physiol Res"},{"key":"44_CR31","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0168-8278(00)80097-5","volume":"32","author":"C. Andant","year":"2000","unstructured":"Andant C, Puy H, Bogard C, et al.: Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol 2000, 32:933\u2013939.","journal-title":"J Hepatol"},{"key":"44_CR32","unstructured":"Harper P, Sardh E, Henrichson A, et al.: Plasma porphyrin precursors and porphyrins in AIP-patients with chronic renal failure [abstract S06-3]. Paper presented at the Porphyrins and Porphyrias International Meeting. Rotterdam, The Netherlands; April 29\u2013May 3, 2007. http:\/\/www2.eur.nl\/fgg\/emco\/porphyrias2007\/downloads\/abstractbook.pdf . Accessed September 26, 2007."},{"key":"44_CR33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00003088-200746040-00006","volume":"46","author":"E. Sardh","year":"2007","unstructured":"Sardh E, Rejkjaer L, Andersson DE, Harper P: Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion. Clin Pharmacokinet 2007, 46:335\u2013349.","journal-title":"Clin Pharmacokinet"},{"key":"44_CR34","unstructured":"Andersson C, Peterson J, Anderson K, et al.: Randomized clinical trial of recombinant human porphobilinogen deaminase (rhPBGD) in acute attacks of porphyria [abstract S06-5]. Paper presented at the Porphyrins and Porphyrias International Meeting. Rotterdam, The Netherlands; April 29\u2013May 3, 2007. http:\/\/www2.eur.nl\/fgg\/emco\/porphyrias2007\/downloads\/abstractbook.pdf . Accessed September 26, 2007."},{"issue":"Suppl2","key":"44_CR35","first-page":"216","volume":"82","author":"G. Nowak","year":"2006","unstructured":"Nowak G, Yin Z, Ellis EC, et al.: Hepatocyte transplantation ameliorates the metabolic abnormality in a mouse model of acute intermittent porphyria. Transplantation 2006, 82(Suppl 2):216\u2013217.","journal-title":"Transplantation"},{"key":"44_CR36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ymthe.2004.05.018","volume":"10","author":"A. Johansson","year":"2004","unstructured":"Johansson A, Nowak G, M\u00f6ller C, et al.: Adenoviral-mediated expression of porphobilinogen deaminase in liver restores the metabolic defect in a mouse model of acute intermittent porphyria. Mol Ther 2004, 10:337\u2013343.","journal-title":"Mol Ther"},{"key":"44_CR37","unstructured":"Gonz\u00e1lez-Aseguinolaza G, Prieto J, Rodr\u00edguez-Pena M, et al.: AAV-mediated liver-specific expression of porphobilinogen deaminase protects against acute attack induced by Phenobarbital injection in a mouse model of acute intermittent porphyria [abstract S05-5]. Paper presented at the Porphyrins and Porphyrias International Meeting. Rotterdam, The Netherlands; April 29\u2013May 3, 2007. http:\/\/www2.eur.nl\/fgg\/emco\/porphyrias2007\/downloads\/abstractbook.pdf . Accessed September 26, 2007."},{"key":"44_CR38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1742-1241.2002.tb11255.x","volume":"56","author":"M.N. Badminton","year":"2002","unstructured":"Badminton MN, Elder GH: Management of acute and cutaneous porphyrias. Int J Clin Pract 2002, 56:272\u2013278.","journal-title":"Int J Clin Pract"},{"key":"44_CR39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/14656566.6.3.377","volume":"6","author":"E. Kostler","year":"2005","unstructured":"Kostler E, Wollina U: Therapy of porphyria cutanea tarda. Expert Opin Pharmacother 2005, 6:377\u2013383.","journal-title":"Expert Opin Pharmacother"},{"key":"44_CR40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/003655100448310","volume":"60","author":"S. Thunell","year":"2000","unstructured":"Thunell S, Harper P: Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda\u2014suggestions for a handling programme. Scand J Clin Lab Invest 2000, 60:561\u2013579.","journal-title":"Scand J Clin Lab Invest"},{"key":"44_CR41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s100380300009","volume":"48","author":"A. Wiman","year":"2003","unstructured":"Wiman A, Floderus Y, Harper P: Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria. J Hum Genet 2003, 48:70\u201376.","journal-title":"J Hum Genet"},{"key":"44_CR42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/003655100448347","volume":"60","author":"S. Thunell","year":"2000","unstructured":"Thunell S, Harper P, Brun A: Porphyrins, porphyrin metabolism and porphyrias. IV. Pathophysiology of erythyropoietic protoporphyria\u2014diagnosis, care and monitoring of the patient. Scand J Clin Lab Invest 2000, 60:581\u2013604.","journal-title":"Scand J Clin Lab Invest"},{"key":"44_CR43","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2133.2006.07472.x","volume":"155","author":"S.A. Holme","year":"2006","unstructured":"Holme SA, Anstey AV, Finlay AY, et al.: Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Br J Dermatol 2006, 155:574\u2013581.","journal-title":"Br J Dermatol"},{"key":"44_CR44","unstructured":"Wahlin S, Harper P, Brun A: Protection from phototoxic injury in erythropoietic protoporphyria [abstract S07-3]. Paper presented at the Porphyrins and Porphyrias International Meeting. Rotterdam, The Netherlands; April 29\u2013May 3, 2007. http:\/\/www2.eur.nl\/fgg\/emco\/porphyrias2007\/downloads\/abstractbook.pdf . Accessed September 26, 2007."},{"key":"44_CR45","first-page":"1009","volume":"56","author":"A.V. Anstey","year":"2007","unstructured":"Anstey AV, Hift RJ: Liver disease in erythropoietic protoporphyria: insights and implications for management. Gut 2007, 56:1009\u20131018.","journal-title":"Gut"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0044-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-007-0044-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0044-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T02:20:16Z","timestamp":1684290016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-007-0044-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1007\/s11938-007-0044-9","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}